Abstract:
A metal complex is provided represented by Formula (1): wherein M represents a prescribed metal atom; RP1, RP2, RP3, RP4, RP5, and RP6 each independently represent a hydrogen atom or a prescribed group, wherein RP1 and RP2 may be bonded together to form a ring structure, RP2 and RP3 may be bonded together to form a ring structure, and RP3 and RP4 may be bonded together to form a ring structure, provided that at least one of RP1, RP2, RP3, and RP4 is a dendron and at least one of RP5 and RP6 is an aryl group or a monovalent heterocyclic group; m is an integer of 1 to 3 and n is an integer of 0 to 2, wherein m+n is 2 or 3; and a moiety represented by Formula (2) represents a bidentate ligand: wherein Rx and Ry each independently represent a prescribed atom.
Abstract:
Arranging an application apparatus, an exposure apparatus, a developing apparatus, and similar apparatus together within a large yellow room makes it difficult to change a layout in association with a change of a recipe and to streamline a layout area and similar parameter. A yellow room system includes: a plurality of portable unit process apparatuses 50 that each have the same standardized outer shape and include a yellow room configured to shield a exposure light to a photosensitive material formed on a workpiece; conveyance containers 11 and 25 that convey the workpiece between the unit process apparatuses and itself is formed as the yellow room; and a light-shielding coupling structure that couples the unit process apparatus, which is formed on a docking port 56 disposed in the upper portion of a front chamber 80 of the unit process apparatus 50, and the conveyance containers together.
Abstract:
A tunnel path of the tunnel FET at a source-gate overlap portion is divided into a vertical path vertical to the source-gate overlap portion and a horizontal path extending to a drain in a horizontal direction along a channel interface. A tunnel distance computation section obtains a tunnel distance for each position of a nonlocal electric field band-to-band tunnel, using first and second bends of the mid-gap potential, which are previously stored approximate functions of the mid-gap potential on the vertical and horizontal paths, respectively. A carrier generation rate computation section computes a carrier generation rate due to band-to-band tunneling, based on the tunnel distance at each position of the nonlocal electric field band-to-band tunnel and a band gap.
Abstract:
A phase-change memory and a semiconductor recording/reproducing device capable of reducing consumed power are provided. A SnxTe100-x/Sb2Te3 SL film obtained by depositing a SnxTe100-x film and a Sb2Te3 film layer by layer contains a SnTe/Sb2Te3 superlattice phase formed of SnTe and Sb2Te3, a SnSbTe alloy phase, and a Te phase. The SnTe/Sb2Te3 superlattice phase is diluted by the SnSbTe alloy phase and the Te phase. Here, X of the SnxTe100-x film is represented by 4 at. %≦X≦55 at. %.
Abstract translation:提供了能够降低消耗功率的相变存储器和半导体记录/再现装置。 通过层叠Sn xTe100-x膜和Sb 2 Te 3膜而形成的Sn xTe100-x / Sb 2 Te 3 SL膜包含由SnTe和Sb 2 Te 3,SnSbTe合金相和Te相形成的SnTe / Sb2Te3超晶格相。 SnTe / Sb2Te3超晶相被SnSbTe合金相和Te相稀释。 这里,SnxTe100-x膜的X由4at表示。 %≦̸ X≦̸ 55 at。 %。
Abstract:
A reflection-type light control element according to the present invention is provided with a light control layer configured to exhibit a reversible change between a transparent state and a reflection state in a reversible reaction with a hydrogen and a catalyst layer configured to accelerate the reversible reaction of the light control layer, wherein the reflection-type light control element is such that the light control layer includes an alloy that contains at least one kind of element selected from a group composed of group 2 elements and at least two kinds of elements selected from a group composed of group 3 elements and rare earth elements, or a hydride of the alloy.
Abstract:
Endoglucanase characterized by a decreased degree of activity inhibition by a lignin-derived aromatic compound, and prepared by substituting tryptophan at position 273 in the amino acid sequence of wild-type thermophilic bacterium-derived endoglucanase with an amino acid other than aromatic amino acids.
Abstract:
The wafer polishing apparatus comprises a polishing plate, a polishing head capable of holding a wafer, and a slurry supplying section. The polishing plate includes: a plurality of concentric polishing zones, each of which has a prescribed width for polishing the wafer and on each of which a polishing cloth is adhered; and a groove for discharging slurry being formed between the polishing zones. A head cleaning section, which cleans the polishing head, or a wafer cleaning section, which cleans the polished wafer, is provided to a center part of the polishing plate and located on the inner side of the innermost polishing zone.
Abstract:
A method of manufacturing semiconductor wafers is provided which facilitates formation of orientation flat lines and allows beveling work without problems.The method of manufacturing semiconductor wafers according to the present invention is a method of manufacturing semiconductor wafers, in which a plurality of small-diameter wafers is cut out from a large-diameter semiconductor wafer, the method including: a marking step of forming straight groove-like orientation flat lines by a laser beam so as to cross the respective small-diameter wafers in each row in the large-diameter semiconductor wafer, wherein cutout positions of the small-diameter wafers are aligned in rows in a specific direction, collectively for each of the rows; and a cutting step of cutting out the small-diameter wafers separately from the large-diameter semiconductor wafer by a laser beam after the marking step.
Abstract:
Provided is an organic nanotube having a hydrophobized inner surface, formed by molecules including an asymmetric bipolar lipid molecule represented by the following General Formula (1) and a derivative thereof represented by the following General Formula (2), wherein the organic nanotube has a hydrophilized outer surface and a hydrophobized inner surface of a hollow cylinder and is formed by binary self-assembly, the organic nanotube encapsulates a hydrophobic guest in the hollow cylinder, has a function of refolding a denatured protein, and has a function of sustainably-releasing a hydrophobic drug according to the change in hydrophobicity of the inner surface of the tube or external stimulus, In Formulas (1) and (2), wherein the same symbols have the same meanings, G is a 1-glucopyranosyl group or 2-glucopyranosyl group, and n is an integer of 12 to 22.Particularly, an asymmetric bipolar lipid molecule and an ester thereof respectively represented by general formulae (1) and (2) wherein n is an integer of 18 to 22, both of Z1 and Z2 are single bonds, Y is Gly, m(s) is the same or different integer of 3 to 6, X is OH, and R is a methoxy group, an ethoxy group, or a benzyloxy group are novel substances, and can form a carboxylic acid based asymmetric nanotube by single component self-assembly or binary self-assembly.
Abstract:
An object of the present invention is to provide a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a method for examining liver disease, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a reagent for quantitative determination of a glycoprotein, which is used for the above measurement methods. Furthermore, an object of the present invention is to provide a glycan-marker glycoprotein as an index for clinical conditions of liver disease, which is capable of identifying the clinical conditions of liver disease depending on the progress of liver disease. The method for measuring a glycoprotein is characterized in that: the glycoprotein is at least one glycoprotein selected from alpha-1-acid glycoprotein (AGP) and Mac-2-binding protein (M2BP) contained in a sample collected from a subject; when the glycoprotein is AGP, AGP binding to a first lectin selected from AOL and MAL is measured; and when the glycoprotein is M2BP, M2BP binding to a second lectin selected from WFA, BPL, AAL, RCA120, and TJAII is measured.